Dapagliflozin/Metformin 5/1000mg PO BID Dosing Assessment
No, dapagliflozin/metformin 5/1000mg PO BID is not the standard recommended dosage for adults with type 2 diabetes and normal renal function. The FDA-approved and guideline-recommended dosing for dapagliflozin is once daily, not twice daily, and the typical therapeutic dose is 10 mg once daily for most indications 1.
Standard Dosing According to FDA Label and Guidelines
Dapagliflozin Dosing
- For glycemic control in type 2 diabetes: Start with 5 mg once daily, can increase to 10 mg once daily for additional glycemic benefit 1
- For cardiovascular/renal protection: 10 mg once daily 2, 3
- Frequency: Once daily administration is standard 1
Metformin Dosing
- Standard dosing: 500-1000 mg twice daily is appropriate 4, 5
- Maximum dose: Up to 2000-2550 mg/day divided into 2-3 doses
Why This Specific Combination is Problematic
The 5/1000mg BID regimen you're asking about contains:
- Dapagliflozin 5 mg twice daily (total 10 mg/day) - non-standard frequency
- Metformin 1000 mg twice daily (total 2000 mg/day) - appropriate
Key Issues:
Dapagliflozin is designed for once-daily dosing due to its long half-life and sustained pharmacodynamic effect on renal glucose reabsorption 1
While research shows dapagliflozin can be given twice daily with similar 24-hour glucose excretion 6, 7, this is not FDA-approved or guideline-recommended for clinical practice
The cardiovascular and renal outcome trials that established dapagliflozin's benefits all used once-daily dosing (10 mg daily) 2, 3, 2, 8
Correct Dosing Approach
For a patient with type 2 diabetes and normal renal function (eGFR ≥45 mL/min/1.73 m²):
Option 1: Separate medications
- Dapagliflozin: 10 mg once daily (morning)
- Metformin: 1000 mg twice daily (with meals)
Option 2: If using fixed-dose combination
- Available FDC products typically contain dapagliflozin 5 or 10 mg with metformin 500,850, or 1000 mg
- Dosing: Once or twice daily depending on the specific formulation
- Standard would be dapagliflozin 10 mg/metformin 1000 mg taken once or twice daily to achieve total daily metformin dose
Renal Function Considerations
With normal renal function (eGFR ≥60 mL/min/1.73 m²):
If eGFR 45-59 mL/min/1.73 m²:
- Dapagliflozin 10 mg once daily can continue 4
- Consider reducing metformin to 1000 mg total daily in some patients 5
If eGFR 30-44 mL/min/1.73 m²:
- Dapagliflozin 10 mg once daily can continue for CV/renal benefits 4
- Reduce metformin to maximum 1000 mg daily 4, 5
If eGFR <30 mL/min/1.73 m²:
- Metformin is contraindicated 4, 5
- Dapagliflozin can continue if eGFR ≥25 for non-glycemic benefits 4, 1
Clinical Pitfalls to Avoid
Don't split dapagliflozin dosing - the once-daily regimen is what demonstrated mortality and morbidity benefits in major trials 2, 3, 8
Don't assume BID dosing improves efficacy - research shows similar 24-hour glucose excretion with once vs. twice daily dosing 6, 7, but clinical outcomes data only support once-daily use
Don't forget to assess volume status before initiating dapagliflozin, especially in elderly patients or those on diuretics 1
Don't use dapagliflozin primarily for glucose lowering in patients with eGFR <45 - it's ineffective for glycemic control but maintains CV/renal benefits 1
Bottom Line
The correct regimen for most patients would be dapagliflozin 10 mg once daily plus metformin 1000 mg twice daily (or appropriate dose based on tolerance and renal function). The twice-daily dosing of dapagliflozin lacks clinical trial support for improved outcomes and deviates from FDA-approved labeling 1.